Header Logo

Connection

KAREN RABIN to Antibodies, Bispecific

Back to Details
This is a "connection" page, showing publications KAREN RABIN has written about Antibodies, Bispecific.
KAREN RABIN
Connection Strength
0.216
Antibodies, Bispecific
  1. Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2025 Feb 27; 392(9):875-891.
    View in: PubMed
    Score: 0.216
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.